関連する実験動画
Updated: Jul 16, 2026
07:48
An Orthotopic Bladder Cancer Model for Gene Delivery Studies
Published on: December 1, 2013
13.2K
膀がんによるCVD死亡率:CAPGタンパク質の役割
Junwen Shen1,2, Zhucheng Zhao1,2, Zhaojun Li1,2
1The Department of Urology, The First Affiliated Hospital of Huzhou Normal College, Huzhou, Zhejiang, China.
PloS one
|February 17, 2026
まとめ
心血管疾患 (CVD) は膀がん患者の死亡率を大幅に増加させます. 膀がんにおける高CAPGタンパク質発現は,心臓機能に影響を与えることでCVDのリスクを高め,CAPGを治療目標として示唆しています.
科学分野:
- 腫瘍学 腫瘍学
- 心臓病学 心臓病学
- 分子生物学は分子生物学である.
背景:
- 膀がんは重大な健康上の問題である.
- 心血管疾患 (CVD) は,がん患者の死亡の主な原因です.
- 膀がんとCVDの関連性を理解することは,患者のアウトカムを改善するために極めて重要です.
研究 の 目的:
- 膀がんと心血管疾患 (CVD) 死亡率を結びつけるメカニズムを調査する.
- 膀がんと心不全の併合疾患に関与する重要な分子因子を特定する.
- 膀がん患者のCVDリスクを軽減するための潜在的な治療目標を探求する.
主な方法:
- CVDによる死亡リスクを評価するために,SEERデータベースから大規模なコホート (140,760人の患者) の分析.
- クロス-WGCNAとラッソ回帰の適用で,膀がんと心不全の間の共有遺伝子/タンパク質を特定する.
- 膀がん細胞系と心筋細胞を用いたインビトロ研究で,タンパク質機能と薬効性を評価した.
主要な成果:
- CVDは膀がん患者の主要な死因であり,リスクは18%増加します.
- SFRP1とCAPGは,膀がんと心不全を結びつける重要な血清タンパク質として特定されました.
- CAPGタンパク質発現は,心筋細胞機能に負の影響を及ぼし,SB525334が阻害効果を示し,潜在的な治療標的である.
結論:
- 膀がんの患者はCVDの死亡リスクが高くなります.
- 高濃度のCAPGタンパク質発現は,膀がんにおけるCVDリスクに貢献する重要な要因です.
- CAPGのターゲティングは,膀がん患者のCVD関連の死亡率を減らすために有望な治療戦略を示しています.
関連する概念動画
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
01:25Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
01:30Coronary Artery Disease I: Introduction
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
01:26Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
01:26Coronary Artery Disease IV: Preventive Measures
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...